vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - düslipideemiad - lipiidi modifitseerivad ained - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)